Humana Inc (HUM) is Upgraded by Jefferies to Buy, Price Target at $210

Humana Inc (HUM) was Upgraded by Jefferies to ” Buy” and the brokerage firm has set the Price Target at $210. Earlier the firm had a rating of “Hold ” on the company shares. Jefferies advised their investors in a research report released on Jul 18, 2016.

Many Wall Street Analysts have commented on Humana Inc. Shares were Downgraded by JP Morgan on Jul 8, 2016 to ” Neutral” and Lowered the Price Target to $ 150 from a previous price target of $196 .Company shares were Reiterated by Stifel on May 5, 2016 to “Buy”, Firm has raised the Price Target to $ 220 from a previous price target of $209 .Company shares were Reiterated by RBC Capital Mkts on May 5, 2016 to “Sector Perform”, Firm has raised the Price Target to $ 220 from a previous price target of $209 .

On the company’s financial health, Humana Inc reported $1.86 EPS for the quarter, beating the analyst consensus estimate by $ 0.05 according to the earnings call on May 4, 2016. Analyst had a consensus of $1.81. The company had revenue of $13800.00 million for the quarter, compared to analysts expectations of $13802.44 million. The company’s revenue was down -.2 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $2.47 EPS.

Humana Inc closed down -2.38 points or -1.48% at $158.89 with 16,99,564 shares getting traded on Friday. Post opening the session at $162.41, the shares hit an intraday low of $158.89 and an intraday high of $162.7 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.

In a different news, on Feb 29, 2016, Brian P. Leclaire (SVP & Chief Information Off.) sold 183 shares at $176.11 per share price. According to the SEC, on Mar 12, 2015, James E Murray (EVP & COO) sold 35,220 shares at $160.93 per share price. On Feb 27, 2015, David A Jr/ky Jones (director) sold 6,100 shares at $165.39 per share price, according to the Form-4 filing with the securities and exchange commission.

Humana Inc. (Humana) is a health and well-being company. The Company operates in three segments: Retail Employer Group and Healthcare Services. The Company’s medical and specialty insurance products allow members to access health care services through its network of health care providers. Its Retail Segment consists of products sold on a retail basis to individuals including medical and supplemental benefit plans. Its Employer Group segment consists of products sold to employer groups including medical and supplemental benefit plans as well as health and wellness products. Its Healthcare Services segment consists of businesses which offers services including pharmacy solutions provider services home-based services integrated behavioral health services and predictive modeling and informatics services to other Humana businesses as well as external health plan members external health plans and other employers or individuals.

Humana Inc

Leave a Reply

Humana Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Humana Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.